Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04923789
What this trial is testing

ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Relapsed Non Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University 100
Large-scale testing (Phase 3)Study completedNCT00438958
What this trial is testing

Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
The Canadian Blood and Marrow Transplant Group 230
Large-scale testing (Phase 3)Active Not RecruitingNCT05030155
What this trial is testing

Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)

Who this might be right for
Eosinophilic Granulomatosis With Polyangiitis
Assistance Publique - Hôpitaux de Paris 100
Not applicableStudy completedNCT00741455
What this trial is testing

Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Dartmouth-Hitchcock Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00773838
What this trial is testing

Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Merck Sharp & Dohme LLC 143
Early research (Phase 1)Ended earlyNCT03448978
What this trial is testing

Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma

Who this might be right for
Multiple Myeloma
Cartesian Therapeutics 32
Testing effectiveness (Phase 2)Study completedNCT00211185
What this trial is testing

ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, Peripheral
Eisai Inc. 49
Testing effectiveness (Phase 2)UnknownNCT02248402
What this trial is testing

Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Chonnam National University Hospital 15
Not applicableLooking for participantsNCT05999877
What this trial is testing

PICAROS - Acalabrutinib RWE on 1L CLL in Spain

Who this might be right for
Chronic Lymphocytic Leukemia
AstraZeneca 315
Testing effectiveness (Phase 2)WithdrawnNCT01055301
What this trial is testing

S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Myeloma
SWOG Cancer Research Network
Testing effectiveness (Phase 2)UnknownNCT04329130
What this trial is testing

Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma
Sun Yat-sen University 44
Testing effectiveness (Phase 2)Looking for participantsNCT05848765
What this trial is testing

Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

Who this might be right for
Relapsed Follicular LymphomaRefractory Follicular Lymphoma
University of Birmingham 284
Testing effectiveness (Phase 2)Study completedNCT02099292
What this trial is testing

Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma

Who this might be right for
Relapsed Non-Hodgkin-Lymphoma
Georg Hess, MD 103
Not applicableEnded earlyNCT00748631
What this trial is testing

Treatment of Malignant Vertebral Fractures With Percutaneous Balloon Kyphoplasty.

Who this might be right for
Vertebral FractureMultiple MyelomaOsteolytic Metastases
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)Ended earlyNCT00482053
What this trial is testing

Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

Who this might be right for
Lymphoma, B-cellLymphoma, Non-HodgkinDiffuse Large B-cell Lymphoma (DLBCL)+1 more
Stanford University 3
Testing effectiveness (Phase 2)Study completedNCT01753453
What this trial is testing

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

Who this might be right for
Multiple Myeloma
Sanofi 23
Not applicableUnknownNCT00899119
What this trial is testing

Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Herbert Irving Comprehensive Cancer Center 40
Not applicableUnknownNCT05693519
What this trial is testing

GastroIntestinal Cancer in Children and Adolescents

Who this might be right for
Gastrointestinal CancerColorectal CancerGastric Cancer+4 more
Paul G. Kemps, MD 2,500
Testing effectiveness (Phase 2)Looking for participantsNCT07575919
What this trial is testing

Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Liping Dou 20
Early research (Phase 1)Looking for participantsNCT07333430
What this trial is testing

Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (MM)
Hadassah Medical Organization 60
Next Page